
Gainers
- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition.
- Waitr Holdings Inc. (NASDAQ:WTRH) gained 73.2% to settle at $0.2654.
- Resolute Forest Products Inc. (NYSE:RFP) shares climbed 63% to close at $20.36 after The Paper Excellence Group announced an agreement to acquire the company.
- Kalera Public Limited Company (NASDAQ:KAL) shares gained 57.5% to close at $4.41 after dipping 22% on Tuesday.
- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) gained 48.8% to settle at $0.90 after the company announced FDA clearance of its IND application for nalmefene implant.
- Revelation Biosciences, Inc. (NASDAQ:REVB) jumped 44.4% to close at $1.20.
- Enjoy Technology, Inc. (NASDAQ:ENJY) climbed 35.2% to close at $0.4190 after jumping more than 80% on Tuesday.
- ThermoGenesis Holdings, Inc. (NASDAQ:THMO) gained 30.8% to settle at $0.3022. ThermoGenesis reported in a filing Tuesday that it received a conversion notice from Boyalife Asset Holding II to convert a total of $3m of the outstanding balance of the second amended and restated convertible promissory note issued to Boyalife on April 16, 2018.
- Mynaric AG (NASDAQ:MYNA) jumped 29.2% to close at $8.56 after the company announced a 7.2% stake by L3Harris.
- MediaCo Holding Inc. (NASDAQ:MDIA) gained 29.1% to settle at $2.66.
- Zevia PBC (NYSE:ZVIA) climbed 26.2% to close at $3.56.
- Vigil Neuroscience, Inc. (NASDAQ:VIGL) shares gained 25.7% to close at $3.08.
- Scholar Rock Holding Corporation (NASDAQ:SRRK) climbed 21.8% to close at $7.16.
- PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) rose 21.4% to settle at $0.8002. PhaseBio Pharmaceuticals received notice from Nasdaq of noncompliance with Nasdaq minimum bid price requirement listing rule.
- Shattuck Labs, Inc. (NASDAQ:STTK) jumped 20.9% to settle at $5.20.
- Evofem Biosciences, Inc. (NASDAQ:EVFM) rose 20.9% to close at $1.33.
- Seelos Therapeutics, Inc. (NASDAQ:SEEL) surged 20.5% to settle at $0.89.
- Genetic Technologies Limited (NASDAQ:GENE) gained 20.3% to close at $1.54.
- Symbotic Inc. (NASDAQ:SYM) jumped 20.3% to close at $17.28, possibly on continued strength after Raymond James on Tuesday initiated coverage on the stock with an Outperform rating and $18 price target.
- First Wave BioPharma, Inc. (NASDAQ:FWBI) gained 19.7% to close at $0.2490.
- SCWorx Corp. (NASDAQ:WORX) gained 19.4% to close at $0.7401 after the company reported a common stock purchase agreement with institutional investor on Tuesday.
- Engine Gaming and Media, Inc. (NASDAQ:GAME) rose 18.5% to close at $1.09. Engine Gaming and Media is expected to release fiscal third quarter results on Thursday, July 14, 2022.
- Onion Global Limited (NYSE:OG) surged 18.4% to close at $1.02.
- Uxin Limited (NASDAQ:UXIN) jumped 18% to settle at $0.66 after surging 24% on Tuesday. Uxin recently announced its entry into definitive agreements for financing transaction of $100 million in replacement of the previously announced binding term sheet.
- Organovo Holdings, Inc. (NASDAQ:ONVO) gained 17.7% to close at $2.13.
- Beyond Air, Inc. (NASDAQ:XAIR) rose 17.7% to close at $9.96. Beyond Air Director Robert Carey acquired a total of 175,000 shares at an average price of $6.45.
- Omega Therapeutics, Inc. (NASDAQ:OMGA) gained 17.5% to settle at $4.77.
- Cano Health, Inc. (NYSE:CANO) rose 17.1% to close at $5.63 amid speculation of Humana eyeing acquisition of Cano Health.
- Humanigen, Inc. (NASDAQ:HGEN) gained 14.4% to close at $2.07.
- Zomedica Corp. (NYSE:ZOM) jumped 13.9% to close at $0.2505. Zomedica received a notice of allowance for U.S. patent titled 'Compositions And Methods For Identifying Cancer Cells.'
- Eos Energy Enterprises, Inc. (NASDAQ:EOSE) gained 13.5% to close at $1.43 after the company announced the signing of two orders with Bridgelink Commodities and a Northeast solar developer totaling 1.1 GWh of energy storage capacity, and said its backlog is now over $460 million.
- Decibel Therapeutics, Inc. (NASDAQ:DBTX) rose 13.5% to close at $4.88. Decibel Therapeutics recently reported top-line results from an interim analysis of its ongoing Phase 1b clinical trial of DB-020.
- Veru Inc. (NASDAQ:VERU) jumped 13% to close at $13.02. Veru announced New England Journal of Medicine evidence publication of Phase 3 clinical trial results demonstrating that sabizabulin treatment significantly reduced deaths in high-risk hospitalized COVID-19 patients.
- Rivian Automotive, Inc. (NASDAQ:RIVN) gained 10.4% to close at $29.66 after the company announced it produced 4,401 vehicles and delivered 4,467 vehicles during Q2. The company said these figures remain in line with its expectations.
- Digital Brands Group, Inc. (NASDAQ:DBGI) rose 6% to close at $0.2090.
- Moderna, Inc. (NASDAQ:MRNA) gained 2.6% to close at $159.56 in possible reaction to recent WHO comments stating global COVID-19 cases are up 30% over the last two weeks.